Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT01725100 |
| Title | A Study to Determine the Relative Bioavailability of the MEK Inhibitor, Trametinib, in Subjects With Solid Tumor Malignancies |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | GlaxoSmithKline |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Goodyear | Arizona | 85338 | United States | Details | |
| GSK Investigational Site | Scottsdale | Arizona | 85259 | United States | Details | |
| GSK Investigational Site | Sarasota | Florida | 34232 | United States | Details | |
| GSK Investigational Site | Nashville | Tennessee | 37203 | United States | Details |